Table 3.
Economic Parameters Considered in the Base Case
| Parameter | Cost (€, 2020) |
|---|---|
| Pharmacological costs | |
| Pharmacological cost per cycle; SOC group | 200.90 |
| Pharmacological cost per cycle; FLS group | 203.23 |
| Costs attributed to FLS | |
| FLS cost per patient (initial evaluation) | 362.36 |
| FLS cost per patient (subsequent follow-up) | 157.17 |
| Costs attributed to subsequent fractures | |
| Hip fracture | 9201.84 |
| Vertebral fracture | 2063.86 |
| Forearm fracture | 803.36 |
| Humerus fracture | 844.06 |
| End-of-life costs | |
| End-of-life costs (last month) | 2965.33 |
Abbreviations: FLS, Fracture Liaison Service; SOC, standard of care.